Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups.
about
Less common oral lesions associated with HIV infection: prevalence and classification.Oral mucosal lesions caused by infective microorganisms. I. Viruses and bacteria.Prevalence and classification of HIV-associated oral lesions.Oral hairy leukoplakia.Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients.Oral manifestations of HIVOral effects of drug abuse.HIV-related infections of the oral cavity.Gender differences in oral lesions among persons with HIV disease in Southern India.Indicator disease-guided testing for HIV--the next step for Europe?Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era.Oral manifestations of HIV infection: a Panamerican perspective.Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.Epidemiology of HIV-related oral manifestations in women: a review.Comparison of periodontal disease in HIV seropositive subjects and controls (I). Clinical features.HIV-associated oral lesions; immunologic, virologic and salivary parameters.Factors associated with increased frequency of HIV-related oral candidiasis.Oral diseases, mycology and periodontal microbiology of HIV-1-infected women.Oral manifestations associated with human immunodeficiency virus infection in a Spanish population.Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia.Hairy leucoplakia and HIV-2--a case report and review of the literature.Intergroup comparisons of oral lesions in HIV-positive South Africans.Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong
P2860
Q33501554-C43085BF-2370-4B71-8078-55C0D932691FQ33768630-D135FFD7-3E5D-425D-B1D8-28A74EBBB10DQ34775285-DBFA3C25-2762-40A8-9E8B-56C8247C12C6Q35228304-A9B81CD9-0BF4-4A2D-9B7F-C0E5B8207109Q35228988-2AEB665E-9310-4718-B1BB-F2877C3AEB02Q35561461-55C75977-D280-4EA0-97C0-3579CF43F80FQ36043862-D49C0A0A-05AE-46AE-AC38-7D3803708727Q36043918-BA86EB08-DD00-4264-89BE-23F03B7ECCB1Q36458479-53ECC126-1FA2-47E2-A2C5-1B83349C472AQ37192570-580E8C94-DA53-41AA-A497-E2E4F21679D9Q37480369-ED729B8B-7EF7-46A2-9059-192443CAE5A4Q40484374-59FB21A3-635E-41FA-B41C-571C90AC2429Q40727940-8196B777-E5D3-4B12-B25A-D1EC9479DD5DQ40894699-7E7F5AE2-B7A3-4269-B6FE-18FC150F32F7Q40981456-B4ABD68C-A110-4C44-A0EB-6386B5DFEE96Q44152957-865E62A0-CCA8-45CF-BE7C-95E61E4C5270Q44718316-53E2FB24-CA35-4BFF-989B-AA2946109B48Q45151896-7B074ACC-A5A1-418F-899A-254AEC10683DQ45765414-E59E154D-A39F-4B07-A3C9-D7B55FCD6AACQ45881754-C824242F-AEFB-4446-B8B0-FF5ABD100AC6Q46368213-65A3EBE6-03C7-45B4-BAE7-0D7BBF67650FQ50909676-F172B55A-6AC4-479F-8954-E5FE6F4567D3Q56836280-79786AD3-2FD6-4A58-9CB9-4549592F3A39
P2860
Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Prevalence of oral lesions amo ...... abusers and other risk groups.
@en
Prevalence of oral lesions amo ...... abusers and other risk groups.
@nl
type
label
Prevalence of oral lesions amo ...... abusers and other risk groups.
@en
Prevalence of oral lesions amo ...... abusers and other risk groups.
@nl
prefLabel
Prevalence of oral lesions amo ...... abusers and other risk groups.
@en
Prevalence of oral lesions amo ...... abusers and other risk groups.
@nl
P2093
P1476
Prevalence of oral lesions amo ...... abusers and other risk groups.
@en
P2093
P304
P356
10.1016/0030-4220(90)90322-J
P577
1990-02-01T00:00:00Z